Careteq Ltd.
AASX:CTQ0.01
AUD
+0.00
(+8.33%)
Careteq Ltd.
ASX:CTQ
(Australian Securities Exchange)
Recent
price
0.01
P/E
ratio
- -
div
yld
4.00%
ROIC.AI
Capital Structure
AUD
•
in mil. unless spec.Working Capital
AUD
•
in mil. unless spec.Growth Rates
AUD
•
in mil. unless spec.Semi-annual Revenue
AUD
•
in mil. unless spec.Semi-annual Earnings Per Share
AUD
•
in mil. unless spec.Semi-annual Dividends Per Share
AUD
•
in mil. unless spec.- Similar Companies
- Business
- Careteq Limited (ASX:CTQ) is an Australian health-tech company focused on medication management solutions for health, aged, and home care sectors. The company offers Residential Medication Management Reviews (RMMRs) and Home Medicines Reviews (HMRs) through its fully owned brands Embedded Health Solutions (EHS), which provides comprehensive aged care medication management; and HMR Referrals, a SaaS platform that matches general practitioners with accredited pharmacists to streamline HMRs, improve patient outcomes, and reduce medication-related harm such as adverse drug reactions and falls risk. Founded in 2016 and headquartered in Melbourne, Victoria, Careteq operates primarily in Australia with an office in Las Vegas, Nevada, targeting patients aged 65+ on multiple medications, healthcare providers, and aged care facilities. Recent developments include the acquisition of the remaining 45% stake in Embedded Health Solutions for A$2.4 million in August 2024, enhancing full ownership and operational control; divestment of its Sofihub assistive living technology business for approximately A$0.58 million in cash in August 2024 to streamline focus on medication management; formation of a joint venture with Mederev Pty Ltd to bolster EHS profitability; strategic partnerships with MedicAlert Foundation to improve medication safety and with National Seniors Australia for expanded market reach; and release of its 2025 preliminary results alongside Q3 FY25 activities report noting platform integration progress and revenue growth exceeding projections.
Company News
Small cap Watch: Biotech, gold explorers and consumer brands deliver key updates